{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T03:13:22Z","timestamp":1785813202956,"version":"3.56.0"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T00:00:00Z","timestamp":1761782400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T00:00:00Z","timestamp":1761782400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100012292","name":"Gerstner Family Foundation","doi-asserted-by":"publisher","award":["Gerstner Family Foundation"],"award-info":[{"award-number":["Gerstner Family Foundation"]}],"id":[{"id":"10.13039\/100012292","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"DOI":"10.1186\/s13287-025-04674-y","type":"journal-article","created":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T00:51:34Z","timestamp":1761785494000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Intra-articular delivery of allogeneic bone marrow derived mesenchymal stromal cells (BM-MSCs) for painful lumbar facet arthropathy: a phase I clinical trial"],"prefix":"10.1186","volume":"16","clinical-trial-number":[{"clinical-trial-number":"nct04410731","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Wenchun","family":"Qu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nisha C.","family":"Durand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vance L.","family":"Lehman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael D.","family":"Osborne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey A.","family":"Stone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sahil","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica","family":"Engelberg-Cook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elani F.","family":"Wiest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Drew M.","family":"Witter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn A.","family":"Siebenaler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfredo","family":"Qui\u00f1ones-Hinojosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abba C.","family":"Zubair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,30]]},"reference":[{"key":"4674_CR1","doi-asserted-by":"publisher","unstructured":"de Souza IMB, Merini LR, Ramos LAV, Passaro AC, Franca JID, Marques AP. Prevalence of low back pain and associated factors in older adults: Amazonia Brazilian community Study. Healthcare (Basel). 2021;5(5). https:\/\/doi.org\/10.3390\/healthcare9050539.","DOI":"10.3390\/healthcare9050539"},{"issue":"4","key":"4674_CR2","doi-asserted-by":"publisher","first-page":"e064119","DOI":"10.1136\/bmjopen-2022-064119","volume":"25","author":"F Fatoye","year":"2023","unstructured":"Fatoye F, Gebrye T, Mbada CE, Useh U. Clinical and economic burden of low back pain in low- and middle-income countries: a systematic review. BMJ Open Apr. 2023;25(4):e064119. https:\/\/doi.org\/10.1136\/bmjopen-2022-064119.","journal-title":"BMJ Open Apr"},{"issue":"6","key":"4674_CR3","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/j.spinee.2010.03.032","volume":"10","author":"S Dagenais","year":"2010","unstructured":"Dagenais S, Tricco AC, Haldeman S. Synthesis of recommendations for the assessment and management of low back pain from recent clinical practice guidelines. Spine J Jun. 2010;10(6):514\u201329. https:\/\/doi.org\/10.1016\/j.spinee.2010.03.032.","journal-title":"Spine J Jun"},{"key":"4674_CR4","doi-asserted-by":"publisher","unstructured":"Kalichman L, Li L, Kim DH et al. Facet joint osteoarthritis and low back pain in the community-based population. Spine (Phila Pa 1976). Nov 1 2008;33(23):2560-5. https:\/\/doi.org\/10.1097\/BRS.0b013e318184ef95","DOI":"10.1097\/BRS.0b013e318184ef95"},{"issue":"4","key":"4674_CR5","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1038\/nrrheum.2012.199","volume":"9","author":"AC Gellhorn","year":"2013","unstructured":"Gellhorn AC, Katz JN, Suri P. Osteoarthritis of the spine: the facet joints. Nat Rev Rheumatol Apr. 2013;9(4):216\u201324. https:\/\/doi.org\/10.1038\/nrrheum.2012.199.","journal-title":"Nat Rev Rheumatol Apr"},{"issue":"1","key":"4674_CR6","doi-asserted-by":"publisher","first-page":"83","DOI":"10.36076\/ppj.2002\/5\/83","volume":"5","author":"L Manchikanti","year":"2002","unstructured":"Manchikanti L, Singh V. Review of chronic low back pain of facet joint origin. Pain Physician Jan. 2002;5(1):83\u2013101.","journal-title":"Pain Physician Jan"},{"issue":"5","key":"4674_CR7","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1007\/s13244-018-0638-x","volume":"9","author":"R Perolat","year":"2018","unstructured":"Perolat R, Kastler A, Nicot B, et al. Facet joint syndrome: from diagnosis to interventional management. Insights Imaging Oct. 2018;9(5):773\u201389. https:\/\/doi.org\/10.1007\/s13244-018-0638-x.","journal-title":"Insights Imaging Oct"},{"issue":"2","key":"4674_CR8","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.mcna.2019.10.007","volume":"104","author":"B Abramoff","year":"2020","unstructured":"Abramoff B, Caldera FE, Osteoarthritis. Pathology, Diagnosis, and treatment options. Med Clin North Am Mar. 2020;104(2):293\u2013311. https:\/\/doi.org\/10.1016\/j.mcna.2019.10.007.","journal-title":"Med Clin North Am Mar"},{"issue":"5","key":"4674_CR9","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1002\/biof.1374","volume":"10","author":"V Volarevic","year":"2017","unstructured":"Volarevic V, Gazdic M, Simovic Markovic B, Jovicic N, Djonov V, Arsenijevic N. Mesenchymal stem cell-derived factors: Immuno-modulatory effects and therapeutic potential. Biofactors Sep. 2017;10(5):633\u201344. https:\/\/doi.org\/10.1002\/biof.1374.","journal-title":"Biofactors Sep"},{"issue":"8","key":"4674_CR10","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.3174\/ajnr.A2696","volume":"33","author":"JL Bykowski","year":"2012","unstructured":"Bykowski JL, Wong WH. Role of facet joints in spine pain and image-guided treatment: a review. AJNR Am J Neuroradiol Sep. 2012;33(8):1419\u201326. https:\/\/doi.org\/10.3174\/ajnr.A2696.","journal-title":"AJNR Am J Neuroradiol Sep"},{"key":"4674_CR11","doi-asserted-by":"publisher","first-page":"2318","DOI":"10.1016\/j.biopha.2018.11.099","volume":"109","author":"CR Harrell","year":"2019","unstructured":"Harrell CR, Markovic BS, Fellabaum C, Arsenijevic A, Volarevic V. Mesenchymal stem cell-based therapy of osteoarthritis: current knowledge and future perspectives. Biomed Pharmacother Jan. 2019;109:2318\u201326. https:\/\/doi.org\/10.1016\/j.biopha.2018.11.099.","journal-title":"Biomed Pharmacother Jan"},{"key":"4674_CR12","doi-asserted-by":"publisher","unstructured":"Evans CH. Nov. Advances in regenerative orthopedics. Mayo Clin Proc. 2013;88(11):1323-39. https:\/\/doi.org\/10.1016\/j.mayocp.2013.04.027","DOI":"10.1016\/j.mayocp.2013.04.027"},{"issue":"7","key":"4674_CR13","doi-asserted-by":"publisher","first-page":"847","DOI":"10.5966\/sctm.2015-0245","volume":"5","author":"YM Pers","year":"2016","unstructured":"Pers YM, Rackwitz L, Ferreira R, et al. Adipose mesenchymal stromal Cell-Based therapy for severe osteoarthritis of the knee: A phase I Dose-Escalation trial. Stem Cells Transl Med Jul. 2016;5(7):847\u201356. https:\/\/doi.org\/10.5966\/sctm.2015-0245.","journal-title":"Stem Cells Transl Med Jul"},{"issue":"4","key":"4674_CR14","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1016\/j.arthro.2012.11.017","volume":"29","author":"YG Koh","year":"2013","unstructured":"Koh YG, Jo SB, Kwon OR, et al. Mesenchymal stem cell injections improve symptoms of knee osteoarthritis. Arthroscopy Apr. 2013;29(4):748\u201355. https:\/\/doi.org\/10.1016\/j.arthro.2012.11.017.","journal-title":"Arthroscopy Apr"},{"issue":"1","key":"4674_CR15","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1186\/s13075-016-1195-7","volume":"20","author":"PK Gupta","year":"2016","unstructured":"Gupta PK, Chullikana A, Rengasamy M, et al. Efficacy and safety of adult human bone marrow-derived, cultured, pooled, allogeneic mesenchymal stromal cells (Stempeucel(R)): preclinical and clinical trial in osteoarthritis of the knee joint. Arthritis Res Ther Dec. 2016;20(1):301. https:\/\/doi.org\/10.1186\/s13075-016-1195-7.","journal-title":"Arthritis Res Ther Dec"},{"key":"4674_CR16","doi-asserted-by":"publisher","unstructured":"Jo CH, Chai JW, Jeong EC, et al. Intra-articular injection of mesenchymal stem cells for the treatment of osteoarthritis of the knee: A 2-Year Follow-up study. Am J Sports Med. Oct 2017;45(12):2774\u201383. https:\/\/doi.org\/10.1177\/0363546517716641.","DOI":"10.1177\/0363546517716641"},{"issue":"5","key":"4674_CR17","doi-asserted-by":"publisher","first-page":"e1181","DOI":"10.1097\/PR9.0000000000001181","volume":"9","author":"D Yan","year":"2024","unstructured":"Yan D, Zubair AC, Osborne MD, et al. CellKine clinical trial: first report from a phase 1 trial of allogeneic bone marrow-derived mesenchymal stem cells in subjects with painful lumbar facet joint arthropathy. Pain Rep Oct. 2024;9(5):e1181. https:\/\/doi.org\/10.1097\/PR9.0000000000001181.","journal-title":"Pain Rep Oct"},{"key":"4674_CR18","doi-asserted-by":"publisher","unstructured":"Shapiro SA, Kazmerchak SE, Heckman MG, Zubair AC, O\u2019Connor MIA, Prospective. Single-Blind, Placebo-Controlled trial of bone marrow aspirate concentrate for knee osteoarthritis. Am J Sports Med. Jan 2017;45(1):82\u201390. https:\/\/doi.org\/10.1177\/0363546516662455.","DOI":"10.1177\/0363546516662455"},{"issue":"2","key":"4674_CR19","doi-asserted-by":"publisher","first-page":"90","DOI":"10.2106\/JBJS.M.00058","volume":"15","author":"CT Vangsness Jr","year":"2014","unstructured":"Vangsness CT Jr., Farr J 2nd, Boyd J, Dellaero DT, Mills CR, LeRoux-Williams M. Adult human mesenchymal stem cells delivered via intra-articular injection to the knee following partial medial meniscectomy: a randomized, double-blind, controlled study. J Bone Joint Surg Am Jan. 2014;15(2):90\u20138. https:\/\/doi.org\/10.2106\/JBJS.M.00058.","journal-title":"J Bone Joint Surg Am Jan"},{"issue":"6","key":"4674_CR20","first-page":"336","volume":"18","author":"M Emadedin","year":"2015","unstructured":"Emadedin M, Ghorbani Liastani M, Fazeli R, et al. Long-Term Follow-up of Intra-articular injection of autologous mesenchymal stem cells in patients with Knee, Ankle, or hip osteoarthritis. Arch Iran Med Jun. 2015;18(6):336\u201344.","journal-title":"Arch Iran Med Jun"},{"issue":"2","key":"4674_CR21","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1093\/jhps\/hnx011","volume":"4","author":"R Mardones","year":"2017","unstructured":"Mardones R, Jofre CM, Tobar L, Minguell JJ. Mesenchymal stem cell therapy in the treatment of hip osteoarthritis. J Hip Preserv Surg Jul. 2017;4(2):159\u201363. https:\/\/doi.org\/10.1093\/jhps\/hnx011.","journal-title":"J Hip Preserv Surg Jul"},{"issue":"1","key":"4674_CR22","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1186\/s13018-017-0689-6","volume":"12","author":"M Al-Najar","year":"2017","unstructured":"Al-Najar M, Khalil H, Al-Ajlouni J, et al. Intra-articular injection of expanded autologous bone marrow mesenchymal cells in moderate and severe knee osteoarthritis is safe: a phase I\/II study. J Orthop Surg Res Dec. 2017;12(1):190. https:\/\/doi.org\/10.1186\/s13018-017-0689-6.","journal-title":"J Orthop Surg Res Dec"},{"issue":"5","key":"4674_CR23","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1002\/stem.1634","volume":"32","author":"CH Jo","year":"2014","unstructured":"Jo CH, Lee YG, Shin WH, et al. Intra-articular injection of mesenchymal stem cells for the treatment of osteoarthritis of the knee: a proof-of-concept clinical trial. Stem Cells May. 2014;32(5):1254\u201366. https:\/\/doi.org\/10.1002\/stem.1634.","journal-title":"Stem Cells May"},{"issue":"1","key":"4674_CR24","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1186\/s12967-016-0998-2","volume":"26","author":"JM Lamo-Espinosa","year":"2016","unstructured":"Lamo-Espinosa JM, Mora G, Blanco JF, et al. Intra-articular injection of two different doses of autologous bone marrow mesenchymal stem cells versus hyaluronic acid in the treatment of knee osteoarthritis: multicenter randomized controlled clinical trial (phase I\/II). J Transl Med Aug. 2016;26(1):246. https:\/\/doi.org\/10.1186\/s12967-016-0998-2.","journal-title":"J Transl Med Aug"},{"issue":"2","key":"4674_CR25","doi-asserted-by":"publisher","first-page":"1550001","DOI":"10.1142\/S1793984415500014","volume":"1","author":"A Gray","year":"2015","unstructured":"Gray A, Marrero-Berrios I, Ghodbane M, et al. Effect of local anesthetics on human mesenchymal stromal cell secretion. Nano Life Jun. 2015;1(2):1550001\u201314. https:\/\/doi.org\/10.1142\/S1793984415500014.","journal-title":"Nano Life Jun"},{"key":"4674_CR26","doi-asserted-by":"publisher","unstructured":"Wu T, Nie H, Dietz AB, et al. Cytotoxic effects of nonionic iodinated contrast agent on human Adipose-Derived mesenchymal stem cells. PM R Jun. 2018;1. https:\/\/doi.org\/10.1016\/j.pmrj.2018.05.022.","DOI":"10.1016\/j.pmrj.2018.05.022"},{"issue":"1","key":"4674_CR27","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.1038\/s41467-024-46259-y","volume":"1","author":"M Bydon","year":"2024","unstructured":"Bydon M, Qu W, Moinuddin FM, et al. Intrathecal delivery of adipose-derived mesenchymal stem cells in traumatic spinal cord injury: phase I trial. Nat Commun Apr. 2024;1(1):2201. https:\/\/doi.org\/10.1038\/s41467-024-46259-y.","journal-title":"Nat Commun Apr"},{"issue":"2","key":"4674_CR28","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.spinee.2020.10.004","volume":"21","author":"K Amirdelfan","year":"2021","unstructured":"Amirdelfan K, Bae H, McJunkin T, et al. Allogeneic mesenchymal precursor cells treatment for chronic low back pain associated with degenerative disc disease: a prospective randomized, placebo-controlled 36-month study of safety and efficacy. Spine J Feb. 2021;21(2):212\u201330. https:\/\/doi.org\/10.1016\/j.spinee.2020.10.004.","journal-title":"Spine J Feb"},{"issue":"5","key":"4674_CR29","doi-asserted-by":"publisher","first-page":"725","DOI":"10.3171\/2020.8.SPINE191551","volume":"1","author":"A Ibaseta","year":"2021","unstructured":"Ibaseta A, Rahman R, Andrade NS, et al. Determining validity, discriminant ability, responsiveness, and minimal clinically important differences for PROMIS in adult spinal deformity. J Neurosurg Spine May. 2021;1(5):725\u201333. https:\/\/doi.org\/10.3171\/2020.8.SPINE191551.","journal-title":"J Neurosurg Spine May"},{"issue":"1","key":"4674_CR30","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.pain.2010.04.025","volume":"150","author":"D Amtmann","year":"2010","unstructured":"Amtmann D, Cook KF, Jensen MP, et al. Development of a PROMIS item bank to measure pain interference. Pain Jul. 2010;150(1):173\u201382. https:\/\/doi.org\/10.1016\/j.pain.2010.04.025.","journal-title":"Pain Jul"},{"issue":"4","key":"4674_CR31","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1111\/j.1526-4637.2007.00313.x","volume":"9","author":"LF Czervionke","year":"2008","unstructured":"Czervionke LF, Fenton DS. Fat-saturated MR imaging in the detection of inflammatory facet arthropathy (facet synovitis) in the lumbar spine. Pain Med May-Jun. 2008;9(4):400\u20136. https:\/\/doi.org\/10.1111\/j.1526-4637.2007.00313.x.","journal-title":"Pain Med May-Jun"},{"key":"4674_CR32","doi-asserted-by":"publisher","unstructured":"Carneiro DC, Araujo LT, Santos GC, et al. Clinical trials with mesenchymal stem cell therapies for osteoarthritis: challenges in the regeneration of articular cartilage. Int J Mol Sci Jun. 2023;9(12). https:\/\/doi.org\/10.3390\/ijms24129939.","DOI":"10.3390\/ijms24129939"},{"issue":"7","key":"4674_CR33","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1007\/s00402-019-03267-8","volume":"140","author":"F Migliorini","year":"2020","unstructured":"Migliorini F, Rath B, Colarossi G, et al. Improved outcomes after mesenchymal stem cells injections for knee osteoarthritis: results at 12-months follow-up: a systematic review of the literature. Arch Orthop Trauma Surg Jul. 2020;140(7):853\u201368. https:\/\/doi.org\/10.1007\/s00402-019-03267-8.","journal-title":"Arch Orthop Trauma Surg Jul"},{"issue":"7","key":"4674_CR34","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1007\/s00402-019-03140-8","volume":"139","author":"SH Kim","year":"2019","unstructured":"Kim SH, Ha CW, Park YB, Nam E, Lee JE, Lee HJ. Intra-articular injection of mesenchymal stem cells for clinical outcomes and cartilage repair in osteoarthritis of the knee: a meta-analysis of randomized controlled trials. Arch Orthop Trauma Surg Jul. 2019;139(7):971\u201380. https:\/\/doi.org\/10.1007\/s00402-019-03140-8.","journal-title":"Arch Orthop Trauma Surg Jul"},{"issue":"7","key":"4674_CR35","doi-asserted-by":"publisher","first-page":"2298","DOI":"10.1016\/j.arthro.2021.02.045","volume":"37","author":"D Zhao","year":"2021","unstructured":"Zhao D, Pan JK, Yang WY, et al. Intra-Articular injections of Platelet-Rich Plasma, adipose mesenchymal stem cells, and bone marrow mesenchymal stem cells associated with better outcomes than hyaluronic acid and saline in knee osteoarthritis: A systematic review and network Meta-analysis. Arthroscopy Jul. 2021;37(7):2298\u2013e231410. https:\/\/doi.org\/10.1016\/j.arthro.2021.02.045.","journal-title":"Arthroscopy Jul"},{"issue":"10","key":"4674_CR36","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1093\/stcltm\/szae049","volume":"10","author":"J Trapana","year":"2024","unstructured":"Trapana J, Weinerman J, Lee D, et al. Cell-based therapy in the treatment of musculoskeletal diseases. Stem Cells Transl Med. Oct 2024;10(10):959\u201378. https:\/\/doi.org\/10.1093\/stcltm\/szae049.","journal-title":"Stem Cells Transl Med"},{"issue":"1","key":"4674_CR37","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.pmrj.2013.05.007","volume":"6","author":"J Bashir","year":"2014","unstructured":"Bashir J, Sherman A, Lee H, Kaplan L, Hare JM. Mesenchymal stem cell therapies in the treatment of musculoskeletal diseases. PM R Jan. 2014;6(1):61\u20139. https:\/\/doi.org\/10.1016\/j.pmrj.2013.05.007.","journal-title":"PM R Jan"},{"issue":"6","key":"4674_CR38","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1002\/sctm.18-0122","volume":"8","author":"WS Lee","year":"2019","unstructured":"Lee WS, Kim HJ, Kim KI, Kim GB, Jin W. Intra-Articular injection of autologous adipose Tissue-Derived mesenchymal stem cells for the treatment of knee osteoarthritis: A phase IIb, Randomized, Placebo-Controlled clinical trial. Stem Cells Transl Med Jun. 2019;8(6):504\u201311. https:\/\/doi.org\/10.1002\/sctm.18-0122.","journal-title":"Stem Cells Transl Med Jun"},{"issue":"7","key":"4674_CR39","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1093\/stcltm\/szac032","volume":"20","author":"W Qu","year":"2022","unstructured":"Qu W, Wang Z, Engelberg-Cook E, et al. Efficacy and safety of MSC cell therapies for hospitalized patients with COVID-19: A systematic review and Meta-Analysis. Stem Cells Transl Med Jul. 2022;20(7):688\u2013703. https:\/\/doi.org\/10.1093\/stcltm\/szac032.","journal-title":"Stem Cells Transl Med Jul"},{"issue":"1","key":"4674_CR40","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s12028-023-01897-w","volume":"41","author":"NC Durand","year":"2024","unstructured":"Durand NC, Kim HG, Patel VN, et al. Mesenchymal stem cell therapy in acute intracerebral hemorrhage: A Dose-Escalation safety and tolerability trial. Neurocrit Care Aug. 2024;41(1):59\u201369. https:\/\/doi.org\/10.1007\/s12028-023-01897-w.","journal-title":"Neurocrit Care Aug"},{"issue":"2","key":"4674_CR41","doi-asserted-by":"publisher","first-page":"e25","DOI":"10.1097\/TP.0000000000003471","volume":"1","author":"DC Noriega","year":"2021","unstructured":"Noriega DC, Ardura F, Hernandez-Ramajo R, et al. Treatment of degenerative disc disease with allogeneic mesenchymal stem cells: Long-term Follow-up results. Transplantation Feb. 2021;1(2):e25\u20137. https:\/\/doi.org\/10.1097\/TP.0000000000003471.","journal-title":"Transplantation Feb"},{"issue":"12","key":"4674_CR42","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1097\/TP.0b013e318291a2da","volume":"27","author":"L Orozco","year":"2013","unstructured":"Orozco L, Munar A, Soler R, et al. Treatment of knee osteoarthritis with autologous mesenchymal stem cells: a pilot study. Transplantation Jun. 2013;27(12):1535\u201341. https:\/\/doi.org\/10.1097\/TP.0b013e318291a2da.","journal-title":"Transplantation Jun"},{"issue":"6","key":"4674_CR43","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1016\/j.knee.2012.04.001","volume":"19","author":"YG Koh","year":"2012","unstructured":"Koh YG, Choi YJ. Infrapatellar fat pad-derived mesenchymal stem cell therapy for knee osteoarthritis. Knee Dec. 2012;19(6):902\u20137. https:\/\/doi.org\/10.1016\/j.knee.2012.04.001.","journal-title":"Knee Dec"},{"issue":"12","key":"4674_CR44","doi-asserted-by":"publisher","first-page":"2020","DOI":"10.1016\/j.arthro.2013.09.074","volume":"29","author":"KL Wong","year":"2013","unstructured":"Wong KL, Lee KB, Tai BC, Law P, Lee EH, Hui JH. Injectable cultured bone marrow-derived mesenchymal stem cells in varus knees with cartilage defects undergoing high tibial osteotomy: a prospective, randomized controlled clinical trial with 2 years\u2019 follow-up. Arthroscopy Dec. 2013;29(12):2020\u20138. https:\/\/doi.org\/10.1016\/j.arthro.2013.09.074.","journal-title":"Arthroscopy Dec"},{"key":"4674_CR45","doi-asserted-by":"publisher","first-page":"9149315","DOI":"10.1155\/2021\/9149315","volume":"2021","author":"B Xie","year":"2021","unstructured":"Xie B, Chen S, Xu Y, et al. Clinical efficacy and safety of human mesenchymal stem cell therapy for degenerative disc disease: A systematic review and Meta-Analysis of randomized controlled trials. Stem Cells Int. 2021;2021:9149315. https:\/\/doi.org\/10.1155\/2021\/9149315.","journal-title":"Stem Cells Int"},{"issue":"8","key":"4674_CR46","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1097\/TP.0000000000001484","volume":"101","author":"DC Noriega","year":"2017","unstructured":"Noriega DC, Ardura F, Hernandez-Ramajo R, et al. Intervertebral disc repair by allogeneic mesenchymal bone marrow cells: A randomized controlled trial. Transplantation Aug. 2017;101(8):1945\u201351. https:\/\/doi.org\/10.1097\/TP.0000000000001484.","journal-title":"Transplantation Aug"},{"issue":"1","key":"4674_CR47","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.pmn.2021.07.001","volume":"23","author":"B Resnick","year":"2022","unstructured":"Resnick B, Galik E, Kolanowski A, et al. The relationship between Pain, Function, Behavioral, and psychological symptoms of dementia and quality of life. Pain Manag Nurs Feb. 2022;23(1):55\u201361. https:\/\/doi.org\/10.1016\/j.pmn.2021.07.001.","journal-title":"Pain Manag Nurs Feb"},{"key":"4674_CR48","doi-asserted-by":"publisher","first-page":"335","DOI":"10.2147\/JMDH.S288401","volume":"14","author":"T Mallick-Searle","year":"2021","unstructured":"Mallick-Searle T, Sharma K, Toal P, Gutman A. Pain and function in chronic musculoskeletal Pain-Treating the whole person. J Multidiscip Healthc. 2021;14:335\u201347. https:\/\/doi.org\/10.2147\/JMDH.S288401.","journal-title":"J Multidiscip Healthc"},{"issue":"9","key":"4674_CR49","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1177\/08982643231153459","volume":"35","author":"MJ Rakutt","year":"2023","unstructured":"Rakutt MJ, Mace RA, Conley CEW, et al. Association of osteoarthritis and functional limitations with cognitive impairment among older adults in the united States. J Aging Health Oct. 2023;35(9):643\u201350. https:\/\/doi.org\/10.1177\/08982643231153459.","journal-title":"J Aging Health Oct"},{"issue":"2","key":"4674_CR50","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.bone.2012.02.012","volume":"51","author":"CR Scanzello","year":"2012","unstructured":"Scanzello CR, Goldring SR. The role of synovitis in osteoarthritis pathogenesis. Bone Aug. 2012;51(2):249\u201357. https:\/\/doi.org\/10.1016\/j.bone.2012.02.012.","journal-title":"Bone Aug"},{"issue":"3","key":"4674_CR51","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/nbt.2816","volume":"32","author":"JA Ankrum","year":"2014","unstructured":"Ankrum JA, Ong JF, Karp JM. Mesenchymal stem cells: immune evasive, not immune privileged. Nat Biotechnol Mar. 2014;32(3):252\u201360. https:\/\/doi.org\/10.1038\/nbt.2816.","journal-title":"Nat Biotechnol Mar"},{"issue":"7","key":"4674_CR52","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.2106\/00004623-200407000-00029","volume":"86","author":"GF Muschler","year":"2004","unstructured":"Muschler GF, Nakamoto C, Griffith LG. Engineering principles of clinical cell-based tissue engineering. J Bone Joint Surg Am Jul. 2004;86(7):1541\u201358. https:\/\/doi.org\/10.2106\/00004623-200407000-00029.","journal-title":"J Bone Joint Surg Am Jul"},{"issue":"1","key":"4674_CR53","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1038\/mt.2011.189","volume":"20","author":"M Francois","year":"2012","unstructured":"Francois M, Romieu-Mourez R, Li M, Galipeau J. Human MSC suppression correlates with cytokine induction of indoleamine 2,3-dioxygenase and bystander M2 macrophage differentiation. Mol Ther Jan. 2012;20(1):187\u201395. https:\/\/doi.org\/10.1038\/mt.2011.189.","journal-title":"Mol Ther Jan"},{"issue":"22","key":"4674_CR54","doi-asserted-by":"publisher","first-page":"2369","DOI":"10.1001\/jama.2012.25321","volume":"12","author":"JM Hare","year":"2012","unstructured":"Hare JM, Fishman JE, Gerstenblith G, et al. Comparison of allogeneic vs autologous bone marrow-derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: the POSEIDON randomized trial. JAMA Dec. 2012;12(22):2369\u201379. https:\/\/doi.org\/10.1001\/jama.2012.25321.","journal-title":"JAMA Dec"},{"issue":"1","key":"4674_CR55","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.jcyt.2012.10.008","volume":"15","author":"CA Bravery","year":"2013","unstructured":"Bravery CA, Carmen J, Fong T, et al. Potency assay development for cellular therapy products: an ISCT review of the requirements and experiences in the industry. Cytotherapy Jan. 2013;15(1):9\u201319. https:\/\/doi.org\/10.1016\/j.jcyt.2012.10.008.","journal-title":"Cytotherapy Jan"},{"issue":"7","key":"4674_CR56","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1177\/0963689719837897","volume":"28","author":"A Musial-Wysocka","year":"2019","unstructured":"Musial-Wysocka A, Kot M, Majka M. The pros and cons of mesenchymal stem Cell-Based therapies. Cell Transplant Jul. 2019;28(7):801\u201312. https:\/\/doi.org\/10.1177\/0963689719837897.","journal-title":"Cell Transplant Jul"},{"issue":"5","key":"4674_CR57","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/nri3209","volume":"25","author":"K Le Blanc","year":"2012","unstructured":"Le Blanc K, Mougiakakos D. Multipotent mesenchymal stromal cells and the innate immune system. Nat Rev Immunol Apr. 2012;25(5):383\u201396. https:\/\/doi.org\/10.1038\/nri3209.","journal-title":"Nat Rev Immunol Apr"},{"issue":"6","key":"4674_CR58","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1097\/01.moh.0000245697.54887.6f","volume":"13","author":"A Keating","year":"2006","unstructured":"Keating A. Mesenchymal stromal cells. Curr Opin Hematol Nov. 2006;13(6):419\u201325. https:\/\/doi.org\/10.1097\/01.moh.0000245697.54887.6f.","journal-title":"Curr Opin Hematol Nov"},{"key":"4674_CR59","doi-asserted-by":"publisher","unstructured":"Caplan AI. Jun. Mesenchymal stem cells: time to change the Name! Stem cells transl med. 2017;6(6):1445\u201351. https:\/\/doi.org\/10.1002\/sctm.17-0051","DOI":"10.1002\/sctm.17-0051"},{"issue":"11","key":"4674_CR60","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1038\/ni.3002","volume":"15","author":"Y Wang","year":"2014","unstructured":"Wang Y, Chen X, Cao W, Shi Y. Plasticity of mesenchymal stem cells in immunomodulation: pathological and therapeutic implications. Nat Immunol Nov. 2014;15(11):1009\u201316. https:\/\/doi.org\/10.1038\/ni.3002.","journal-title":"Nat Immunol Nov"},{"issue":"7","key":"4674_CR61","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1002\/stem.1118","volume":"30","author":"L von Bahr","year":"2012","unstructured":"von Bahr L, Batsis I, Moll G, et al. Analysis of tissues following mesenchymal stromal cell therapy in humans indicates limited long-term engraftment and no ectopic tissue formation. Stem Cells Jul. 2012;30(7):1575\u20138. https:\/\/doi.org\/10.1002\/stem.1118.","journal-title":"Stem Cells Jul"},{"issue":"1","key":"4674_CR62","doi-asserted-by":"publisher","first-page":"95","DOI":"10.5312\/wjo.v6.i1.95","volume":"18","author":"T Mabey","year":"2015","unstructured":"Mabey T, Honsawek S. Cytokines as biochemical markers for knee osteoarthritis. World J Orthop Jan. 2015;18(1):95\u2013105. https:\/\/doi.org\/10.5312\/wjo.v6.i1.95.","journal-title":"World J Orthop Jan"}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-025-04674-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13287-025-04674-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-025-04674-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T00:51:35Z","timestamp":1761785495000},"score":1,"resource":{"primary":{"URL":"https:\/\/stemcellres.biomedcentral.com\/articles\/10.1186\/s13287-025-04674-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,30]]},"references-count":62,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4674"],"URL":"https:\/\/doi.org\/10.1186\/s13287-025-04674-y","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,30]]},"assertion":[{"value":"20 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"W.Q. is supported by Louis V. Gerstner, Jr. Fund at Vanguard Charitable and serves as the Jorge and Leslie Bacardi Associate Director of the Mayo Clinic Center for Regenerative Biotherapeutics in Florida, as well as at the Tissue Engineering Advisory Group for the Alliance for Regenerative Medicine. A.Z. is supported by Skoll Foundation, DeSantis Funds for Cancer Research, and NASA Space Research. J.S. serves as the president of Florida Radiological Society Education Foundation. A.Q. is the founder of DOME Therapeutics and Aqualux. A.Q. is supported by the William J. and Charles H. Mayo Professorship, the Mayo Clinic Clinician Investigator award, the Florida Department of Health Cancer Research Chair Fund, The Monica Flynn Jacoby Endowed Chair, the Richard and Lauralee Uihlein Neurooncology support, as well as the National Institutes of Health (R01CA284268, R01NS129671, R01CA282451). The other authors indicated no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study adhered to the principles outlined in the Declaration of Helsinki and was approved by the Institutional Review Board(IRB) of Mayo Clinic, Florida, USA in April 2020 (Study title: \u201cCELLKINE: Phase I Study Evaluating the Safety and Feasibility of Allogeneic, Culture-Expanded Bone Marrow-Derived Mesenchymal Stem Cells in Subjects with Painful Lumbar Facet Joint Arthropathies\u201d, IRB#: 20\u2013000330). The clinical trial was registered on ClinicalTrials.gov (Identifier: NCT04410731). Written informed consent was obtained from all participants prior to their enrollment in the study. The Human Cell Therapy Laboratory (HCTL) confirmed that human bone marrow collection for MSC manufacturing was conducted under Mayo Clinic IRB approval, with written informed consent obtained from the donor.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}}],"article-number":"596"}}